The Infant Formula Testing Market is expected grow at a CAGR of 6.9% to reach revenue of $20.26 billion by 2023

Infant Formula Testing Market is driven By the growing infant population across the globe

HYDERABAD, TELANGANA, INDIA, August 21, 2018 /EINPresswire.com/ — According to the new market research report by IndustryARC titled “Infant Formula Testing Market: By Test Type (Allergens Testing, Adulteration Testing, Nutritional Analysis, Microbiology Testing), By Technology (NMR Spectroscopy, PCR, Chromatography, Mass Spectrometry, Immunoassay) & By Geography-Forecast(2018-2023)”, the market is driven By the growing infant population across the globe, increase in the number of infant formula products and strict regulations.

Asia Pacific dominates the Infant Formula Testing Market during the Forecast Period

Asia-Pacific holds a major share in the Infant Formula Testing Market, followed by Americas. Rest of the world includes Middle East and Africa. Increase in product introductions and establishment of new regulations drives the growth of RoW. The Asia-Pacific region is driven by large economic developments in China and other developing countries. China is the largest market in Asia-Pacific, with a share of 26.5% in the market. Asia Pacific will experience a growth of $53.4 million by 2023 with a CAGR of 7.9%.

Americas has a huge penetration of baby formula ingredients which drives the need for adulteration testing to be carried out, so that contamination is avoided and labelling is enhanced through proper nutritional analysis.

Selected Analysis done in the full Report:

NMR Spectroscopy or Nuclear Magnetic Spectroscopy is a testing technique in which the nucleus of an atom absorbs the magnetic field and emits electromagnetic field. It can detect adulterants such as melamine, dicyandiamide, protein hydrolysates added into the milk or milk powder for enhancing the protein level. It even improves the detection of addition of sugar in honey.

NMR Spectroscopy can also detect fat content in baby food that is responsible for illnesses conditions related to heart or other concerns. It holds importance in fat labelling. The targeted information of NMR consists of quantification of defined compounds, whereas non-targeted information consists of identification of deviation from typical spectral patterns.

To access / purchase the full report browse the link below:
https://industryarc.com/Report/228/Global-Infant-Formula-testing-Market-report.html

Excerpts on Market Growth Factors:

Stringent regulations on the infant formula products enhances microbiology and allergen testing. This factor will drive the growth of the infant formula testing laboratories during the forecast period.
Growing focus on nutritional labelling will also boost the demand for infant formula testing requirements.
The aim to reduce adulteration products will benefit the Infant Formula Testing Market in the coming years.
Presence of rapid resting methods drives the growth of infant formula testing products.

Talk to one of our sales representative about the full report by providing your details in the below link:
https://industryarc.com/support.php?id=228

Key players of the Infant Formula Testing Market:

SGS is one of the leading players in the Infant Formula Testing Market. Bureau Veritas has also developed its business and expanded its activities to other end industries in ten geographical regions, covering more than 1 million customers.
SGS provides services such as Microbiology testing and contaminant testing. Microbiology testing service can find pathogens present in the food for safety of the product. In contaminant testing, many restricted substances are tested to identify food borne diseases, chemical and microbiological hazards. This is done to ensure that the products are in accordance with the regulations.
Bureau Veritas, established in 2013 acquired Maxxam, a leading food analytics service provider in Canada to enhance its market share in the region. The company provides inspection and laboratory testing service for all types of commodities.

Infant Formula Testing market is segmented as below:

Advent of new technologies and increasing health safety measures will drive the demand for Infant Formula Testing Market in the coming years.

A. Infant Formula Testing Market By Test Type
1. Introduction
2. Allergens Testing
3. Adulteration testing
4. Nutritional Analysis
5. Microbiology Testing
6. Others

B. Infant Formula Testing Market By Technology
1. Introduction
2. NMR Spectroscopy
3. Chromatography
4. Mass Spectrometry
5. Polymerase Chain Reaction
6. Immunoassay
7. Others

C. Infant Formula Testing Market By Geography (covers 12+ countries)

D. Infant Formula Testing Market By Entropy

Companies cited and interviewed

1. Bureau Veritas S.A.
2. Elisa Technologies
3. Eurofins Scientific S.E.
4. Intertek Group Plc
5. Sgs Sa
6. Agilent Technologies
7. Covance
8. Thermo Fisher Scientific
9. Silliker
10. Accugen Laboratories
11. Company 11
12. Company 12
13. Company 13
14. Company 14
15. Company 15+

Related Report:

A. Food Safety Testing Market
https://industryarc.com/Report/10595/food-safety-testing-market.html

B. North America Baby Food Product Market
https://industryarc.com/Report/7520/North-america-baby-food-product-market.html

What can you expect from the report?

The Infant Formula Testing Market Report is Prepared with the Main Agenda to Cover the following 20 points:

1. Market Size by Product Categories & Application 11. Demand Analysis (Revenue & Volume)
2. Market trends & Relevant Market Data 12. Country level Analysis
3. Manufacturer Landscape 13. Competitor Analysis
4. Distributor Landscape 14. Market Shares Analysis
5. Pricing Analysis 15. Value Chain Analysis
6. Top 10 End user Analysis 16. Supply Chain Analysis
7. Product Benchmarking 17. Strategic Analysis
8. Product Developments 18. Current & Future Market Landscape Analysis
9. Mergers & Acquisition Analysis 19. Opportunity Analysis
10. Patent Analysis 20. Revenue and Volume Analysis

Frequently Asked Questions:

Q. Does IndustryARC publish country or application based reports in Infant Formula Testing segment?
Response: Yes, we do have separate reports as mentioned below:

1. Americas Infant Formula Testing Market (2018-2023)
2. Europe Infant Formula Testing Market (2018-2023)
3. Asia Pacific Infant Formula Testing Market (2018-2023)
4. NMR Spectroscopy Infant Formula Testing Market (2018-2023)
5. Chromatography Infant Formula Testing Market (2018-2023)

Q. Does IndustryARC provide customized reports and charge additionally for limited customization?
Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:

1. Increase the level of data in application or end user industry.
2. Increase the number of countries in geography chapter.
3. Find out market shares for other smaller companies or companies which are of interest to you.
4. Company profiles can be requested based on your interest.
5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.

Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

To request for a proposal, provide your details in the below link:
https://industryarc.com/subscription.php

Media Contact:

Mr. Venkat Reddy
Sales Manager
Email: venkat@industryarc.com
Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC
IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, and Life Sciences & Healthcare.
IndustryARC primarily focuses on cutting-edge technologies and newer applications in a market. Our custom research services are designed to provide insights on the constant flux in the global supply–demand gap of markets. Our strong team of analysts enables us to meet the client’s research needs at a rapid speed and with a variety of options.
We look forward to helping the client address its customer needs effectively, stay ahead in the market, become the top competitor, and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Venkat Reddy
IndustryARC
+1-614-588-8538 (Ext-101)
email us here


Source: EIN Presswire

Hand Sanitizer Market is anticipated to hit $1.9 billion by 2023 at a CAGR of 7.8%

Americas hold the largest market share in the Hand Sanitizer Market and is anticipated to reach $603.3 million by 2023 at a CAGR of 5.19%

HYDERABAD, TELANGANA, INDIA, August 21, 2018 /EINPresswire.com/ — According to the new market research report by IndustryARC titled “Hand Sanitizer Market: By Product Type (Foam based, Gel based, Liquid, Wipes, Sprays); By Solution (Alcohol, Triclosan, Quaternary Ammonium Compounds, Silver/iodine); By End user industry (Healthcare, Educational Institution, Domestic/household, Corporate offices, Restaurants and others); By Sales Channel (Online and Offline) & Geography Analysis & Forecast – (2018-2023)”, the market is driven by the prevalent media coverage about disease outbreaks, and also by public awareness campaigns along with large endorsements by global health institutions such as WHO (World Health Organization) that plays a significant role in promoting hand sanitizer products worldwide.

Americas held the largest market share in the Hand Sanitizer Market:

Americas hold the largest market share in the Hand Sanitizer Market and is anticipated to reach $603.3 million by 2023 at a CAGR of 5.19%. However, Asia-Pacific is projected to witness the highest growth rate and is anticipated to reach $627.2 million by 2023 at a CAGR of 12.6%. Increased awareness and adoption, especially in emerging economies, and continuous product and package innovation by the market players, are the major growth factors that propel the growth of Hand Sanitizer Market globally. The key applications include healthcare, educational institutions, corporate offices, restaurants, and public organizations among others.

Selected Value Chain Analysis:

Value chain for hand sanitizers has been established as an interdependent and complex network, comprising of raw material providers, product providers, contract manufacturing firms, health institutes and distributors.
Top players follow a decentralized approach in production, having their manufacturing presence in strategically important, yet low cost countries in each region and serve the end users through local distribution networks. This scenario also boosts the international trade of finished products.
Regulatory bodies approve active compounds, products, product extensions, package designs through thorough analysis of their chemical and physical properties related to the safety and environmental impact while in use. In addition, they also establish and maintain regulations that provide guidelines for manufacturing, storage and distribution of raw materials and finished products. Regulations are set to tighten in the coming years, especially related to the toxicity of the materials.

Collaborative research involving various stakeholders including health institutes is needed, which boosts innovation according to the disease outbreaks, and also the authenticity of the products.
Promotional activities play an important role in boosting the sales of the products. In addition, increasing incidents as well as awareness about flus and contagious diseases also impact the sales trend.
Market players also develop and sell dispensing systems in order to create longer and stronger brand image, while providing the convenience of dispensation.
As packaging designs have become an important factor of differentiation, the innovation of bottles and tubes is set to intensify in the coming years.

To access / purchase the full report browse the link below:
https://industryarc.com/Report/15570/hand-sanitizer-market.html

Excerpts on Market Growth Factors:

The market for Hand Sanitizers is driven by the growing number of infection cases acquired from hospitals. Advances in product preparations such as adding scents, are offering a new opportunity in the global hand sanitizer market.
Highly recommended use of hand purifiers, owing to their effectiveness in killing germs and microorganisms, is projected to drive the sale of hand sanitizing products in the market.
Gels are the widely used form of hand sanitizers globally, and is estimated to reach $1 billion by 2023 at a CAGR of 7.9%.
North America will record the highest growth in population over 65 years of age by 2030, while the number of elderly people in Europe will grow to 29% of its total population by 2050. This will also lead to an increase in dependency of this older generation on elder care facilities, where hand sanitizer market faces increased penetration.

According to WHO, the number of people who die from chronic diseases is set to rise from 40.4% of total deaths in 1990 to 66.7% of all deaths by 2020. The increasing risk of hospital acquired infections and surgical risks due to the rise in chronic diseases has led to the growing focus on reducing the impact of these problems. This has led to increased use of hand sanitizers in order to reduce the impact in hospitals.
Use of hand sanitizers to reduce water usage has been a driver for adoption by an increasingly environmentally aware populace. The rising awareness regarding the health benefits of hand hygiene of these sanitizers has also positively impacted the market.

Talk to one of our sales representative about the full report by providing your details in the below link:
https://industryarc.com/support.php?id=15570

Key players of Hand Sanitizers Market:

Key companies in hand sanitizers market held major part of the total market share. These companies include Gojo Industries Inc.(U.S.), Proctor & Gamble (U.S.), Unilever (U.K.) and Reckitt Benckiser Plc (U.K.).
Reckitt Benckiser held the major market share for hand sanitizer globally. P&G was the second most dominating company, followed by Gojo Industries Inc.
Global hand sanitizer market is fragmented, with multiple regional level players as well as private label brands.

Other key players in the market are Chattem, 3M Company, Best Sanitizers Inc., The Dial Corporation, Nice Pak Products Inc. Skin Visible Inc. and others. These players held a Lion’s share of the hand sanitizers market.
Many local players tend to offer low priced products in order to mark their presence and compete with the international players.
Key players such as GOJO Industries, Inc, Reckitt Benckiser, Chattem, P&G and Unilever are launching new products, partnering with organizations to spread awareness regarding hand care, and thus, adding to the market share and driving the market. Apparently, Gojo hand sanitizers are much popular to their credit.

Hand Sanitizer Market Report is segmented as indicated below.
A. Hand sanitizer Market – By Product Type
1. Foam based
2. Gel based
3. Liquid
4. Wipes
5. Sprays
6. Others

B. Hand sanitizer Market – By Solution
1. Alcohol Based
2. Quaternary Ammonium Compounds Based
3. Triclosan Based
4. Silver/iodine Based
5. Others
C. Hand sanitizer Market – By End user industry
1. Domestic/household
2. Healthcare
3. Educational Institution
4. Corporate offices
5. Restaurants
6. Public organizations
7. Others

D. Hand Sanitizer Market – By sales channel
1. Online sales
2. Offline/Retail sales
2.1. Super markets
2.2. Pharmacies
2.3. Grocery stores
2.4. Specialty Stores
E. Hand Sanitizer Market – By Geography (Covers 9+ Countries)
F. Hand Sanitizer Market By Entropy

Companies Cited/Referenced/Interviewed:
1. Henkel AG & Company, KGAA
2. Medline Industries
3. Kutol Products Company
4. Nice-Pak Products, Inc.
5. Lion Corporation
6. Shanghai Likang Disinfectant Hi-Tech Co; Ltd
7. Company 7
8. Company 8
9. Company 9
10. Company 10+

Related Reports:

A. Cleaning Chemicals in Healthcare
https://industryarc.com/Report/249/Cleaning-Chemicals-healthcare-market-report.html

B. Electric Toothbrush Market
https://industryarc.com/Report/17992/electric-toothbrush-market.html

What can you expect from the report?
The Hand Sanitizers Market Report is Prepared with the Main Agenda to Cover the following 20 points:
1. Market Size by Product Categories
2. Market trends
3. Manufacturer Landscape
4. Distributor Landscape
5. Pricing Analysis
6. Top 10 End user Analysis
7. Product Benchmarking
8. Product Developments
9. Mergers & Acquisition Analysis
10. Patent Analysis
11. Demand Analysis (By Revenue & Volume)
12. Country level Analysis (15+)
13. Competitor Analysis
14. Market Shares Analysis
15. Value Chain Analysis
16. Supply Chain Analysis
17. Strategic Analysis
18. Current & Future Market Landscape Analysis
19. Opportunity Analysis
20. Revenue and Volume Analysis

Frequently Asked Questions:

Q. Does IndustryARC publish country, geography or application based reports in Hand Sanitizer Market?
Response: Yes, we do have separate reports as mentioned below:

1. Americas Market for Hand Sanitizers (2018-2023)
2. Europe Market for Hand Sanitizers (2018-2023)
3. Asia-Pacific Market for Hand Sanitizers (2018-2023)
4. RoW Market for Hand Sanitizers (2018-2023)
5. Foam Based Market for Hand Sanitizers (2018-2023)
6. Gel Based Market for Hand Sanitizers (2018-2023)
7. Liquid Market for Hand Sanitizers (2018-2023)
8. Wipes Market for Hand Sanitizers (2018-2023)
9. Domestic/household Market for Hand Sanitizers (2018-2023)
10. Healthcare Market for Hand Sanitizers (2018-2023)
11. Educational Institutions Market for Hand Sanitizers (2018-2023)
12. Corporate Offices Market for Hand Sanitizers (2018-2023)
13. Restaurants Market for Hand Sanitizers (2018-2023)
14. Public Organizations Market for Hand Sanitizers (2018-2023)
15. Alcohol Based Market for Hand Sanitizers (2018-2023)
16. Quaternary Ammonium Compounds Based Market for Hand Sanitizers (2018-2023)
17. Triclosan Based Market for Hand Sanitizers (2018-2023)

Q. Does IndustryARC customize these reports and charge additionally for limited customization?
Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:

1. Increase the level of data in application or end user industry.
2. Increase the number of countries in geography chapter.
3. Find out market shares for other smaller companies or companies which are of interest to you.
4. Company profiles can be requested based on your interest.
5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.

Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

To request for a proposal, provide your details in the below link:
https://industryarc.com/subscription.php

Media Contact:

Mr. Venkat Reddy
Sales Manager
Email: venkat@industryarc.com
Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC:

IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications in a Market. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business.

We look forward to support the client to be able to better address their customer needs, stay ahead in the market, become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Venkat Reddy
IndustryARC
+1-614-588-8538 (Ext-101)
email us here


Source: EIN Presswire

Gynecology Devices Market Market is anticipated to hit $16.02 billion by 2023 at a CAGR of 4.98%

Americas region holds the largest market share in the Gynecological Devices Market and is anticipated to reach $6.17 billion by 2023 at a CAGR of 4.04%

HYDERABAD, TELANGANA, INDIA, August 21, 2018 /EINPresswire.com/ — According to the new market research report by IndustryARC titled “Gynaecological Devices Market: By Gynaecological products (Endoscopy, endotherapeutic devices, surgical instruments, disposals, implants); By Devices (examination & operation devices, female sterilization devices, endometrial ablation, fluid management devices, curettes, forceps); By End user (hospitals, clinics/ASP, research institutes, diagnostic labs); By Geography – Forecast (2018-2023)”, the market is driven by the specialty clinics pertaining to gynecology and rising populace for diagnosis and treatment of dysfunctional uterine bleeding and hypermenorrhea.

Americas held the largest market share in the Gynecological Devices Market:

Americas region holds the largest market share in the Gynecological Devices Market and is anticipated to reach $6.17 billion by 2023 at a CAGR of 4.04%. However, APAC witnesses highest growth during the forecast period and is expected to reach $5.2 billion by 2023 at a CAGR of 7.14%. North America holds the major share in the global gynecological devices market due to ageing population along the increasing disorder prevalence among the females which is the major driver for gynecological devices market in the region. The key end-users in this region include Hospitals and Clinics among others.

Selected Pricing Analysis done in the full report:

The pricing concept is used to estimate the pricing standards of the various gynecological devices being used in the market. The average selling prices (ASP) differ significantly depending upon the end applications of the products.
The price of these devices differ prominently due to the invasive and non-invasive techniques adopted on the basis of the end applications. However, the prices of the general examination and operation equipment doesn’t vary significantly although the specifications differ according to the devices it is incorporated with.

To access / purchase the full report browse the link below:
https://industryarc.com/Report/4337/Gynaecological-Devices-Market-Research-Report.html

Excerpts on Market Growth Factors:

Hospitals are the major demand areas pertaining to end-users and is estimated to contribute $4,070.33m in revenues for this market by 2022.
Operative laparoscopy are substituting conventional gynecological surgeries. Technological advancements with adoption of robots for gynecological procedures will drive the laparoscopes market
United States is the dominant region for the implementation of laparoscopes in gynecological treatments
The market for gynecological laparoscopes is estimated to reach 793 million by 2023 at a CAGR of 4.33%.
Use of these devices for research, development and training to enhance patient comfort and recovery time is analyzed to propel the market in the future.

Talk to one of our sales representative about the full report by providing your details in the below link:
https://industryarc.com/support.php?id=4337

Key players of Gynecological Devices Market:

Boston Scientific Corporation, one of the key players in healthcare industry, acquired IoGyn Inc., a start-up company that specializes in products for gynecology surgery in May 2014 creating a high growth in Gynecological Devices market
Medtronic Plc. is an Irish Company which manufactures medical device company. It is the world’s largest standalone medical technology company. It is a public-listed company.
Key competitors for Medtronic Plc. include Dow Corning Corp., Saint Gobain and Hitachi Cables America Inc. among many others.

Gynecological Devices Market Report is segmented as indicated below:

A. Gynaecological Devices Market – By Gynaecological products

1. Endoscopy
2. Endotherapeutic devices
3. Energy systems & instruments
4. Imaging systems & video hardware
5. Surgical instruments
6. Disposals
7. Implants

B. Gynaecological Devices Market- By Devices

1. General Examination and Operation Device
2. Gynaecological Examination Couch
3. Female Sterilization and Contraceptive Device
4. Gynaecological Endometrial ablation devices
5. Gynaecological Fluid Management Devices
6. Pelvic floor electrical stimulation devices
7. Pelvic organ prolapse repair devices
8. Hysterometers
9. Cervical cytology brushes
10. Gynaecological dilators
11. Gynaecological finger cots
12. Gynaecological curettes
13. Gynaecological forceps
14. Breast pumps
15. Intrauterine devices
16. Birth pools
17. Fetal monitors and doplers
18. Hysterscopes

C. Gynaecological Devices Market – By End-users
1. Hospitals
2. Clinics/ASCs
3. Research Institutes
4. Diagnostic labs
D. Gynecological Devices Market By Geography (Covers 12 + Countries)
E. Gynecological Devices Market By Entropy

Companies Cited/Referenced/Interviewed:

1. Femcare – Nikomed Limited
2. Karl Storz GmBH & Co. Kg
3. Bayer AG
4. Schmitz U. SÖHNE GmbH & Co. KG
5. Cooper Surgical Inc.
6. Hologic, Inc.
7. Wallach Surgical Devices
8. Johnson & Johnson
9. Company 10+

Related Reports:

A. Laparoscopic Instrument Market
https://industryarc.com/Report/16399/laparoscopic-instruments-market.html

B. Pyrogen Testing Market
https://industryarc.com/Report/16213/pyrogen-testing-market.html

What can you expect from the report?
The Gynecological Devices Market is Prepared with the Main Agenda to Cover the following 20 points:

1. Market Size by Product Categories
2. Market trends
3. Manufacturer Landscape
4. Distributor Landscape
5. Pricing Analysis
6. Top 10 End user Analysis
7. Product Benchmarking
8. Product Developments
9. Mergers & Acquisition Analysis
10. Patent Analysis
11. Demand Analysis (By Revenue & Volume)
12. Country level Analysis (15+)
13. Competitor Analysis
14. Market Shares Analysis
15. Value Chain Analysis
16. Supply Chain Analysis
17. Strategic Analysis
18. Current & Future Market Landscape Analysis
19. Opportunity Analysis
20. Revenue and Volume Analysis

Frequently Asked Questions:

Q. Does IndustryARC publish country, geography or application based reports in Gynecological Devices Market?
Response: Yes, we do have separate reports as mentioned below:

1. Americas Market for Gynecological Devices (2018-2023)
2. Europe Market for Gynecological Devices(2018-2023)
3. APAC Market for Gynecological Devices(2018-2023)
4. RoW Market for Gynecological Devices(2018-2023)
5. By Gynaecological Types Gynecological Devices (2018-2023)
6. By Devices Gynecological Devices (2018-2023)
7. By End-User Gynecological Devices (2018-2023)

Q. Does IndustryARC customize these reports and charge additionally for limited customization?
Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:
1. Increase the level of data in application or end user industry.
2. Increase the number of countries in geography chapter.
3. Find out market shares for other smaller companies or companies which are of interest to you.
4. Company profiles can be requested based on your interest.
5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.

Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

To request for a proposal, provide your details in the below link:
https://industryarc.com/subscription.php

Media Contact:

Mr. Venkat Reddy
Sales Manager
Email: venkat@industryarc.com
Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC:

IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, and Life Sciences & Healthcare.

IndustryARC primarily focuses on cutting-edge technologies and newer applications in a market. Our custom research services are designed to provide insights on the constant flux in the global supply–demand gap of markets. Our strong team of analysts enables us to meet the client’s research needs at a rapid speed and with a variety of options.

We look forward to helping the client address its customer needs effectively, stay ahead in the market, become the top competitor, and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Venkat Reddy
IndustryARC
+1-614-588-8538 (Ext-101)
email us here


Source: EIN Presswire

Global Tissue Banking Market is anticipated to hit $54.76 billion by 2023 at a CAGR of 5.62%

Global Tissue Banking Market is anticipated to reach $17.9 billion by 2023 at a CAGR of 4.26%

HYDERABAD, TELANGANA, INDIA, August 21, 2018 /EINPresswire.com/ — According to the new market research report by IndustryARC titled “Tissue Banking Market: By Tissue (Skin, Heart Valves, Corneas, Umbilical Cord); By Equipment (Cryopreservation, Thawing, Quality Control, Others); By Application (Cosmetic, Therapeutic, Medical Research); By Service (Screening, Serological Testing, Others) & By Geography – Forecast (2018-2023)”, the market is driven by rise in prevalence of chronic diseases and advancements in bio banking technology.

Americas held the largest market share in the Global Tissue Banking Market:

Americas region holds the largest market share and growth in the Global Tissue Banking Market and is anticipated to reach $17.9 billion by 2023 at a CAGR of 4.26%. However, APAC witnesses highest growth during the forecast period and is expected to reach $18.05 billion by 2023 at a CAGR of 7.01%. Americas region is the biggest market for tissue banking presently. The drivers for tissue banking market in the Americas region are public awareness programs, increased spending on healthcare and rise in aging population. There are large number of profit and non-profit companies in the US which act as the mediator between the donor and the recipient. The key end-users including Clinical/Therapeutic, Cosmetic, and Medical Research. In the US, there are 59,271 registered cornea donors which in turn help to perform 40,000 transplants annually.

Selected Market Life Cycle Analysis done in the full report:

The tissue banking market is currently in growth stage because of increased awareness about tissue donation and the increased focus on research to produce regenerative medicine. The blood banking market is expanding mainly through cord blood banking. Umbilical cord and tissue banking widens the options for future potential medical uses. The appetite to intervene aging process has led to flourishing of stem cell research. Hence, the stem cell banks are mushrooming over the globe and the stem cells can be preserved for more than 20 years making it the most lucrative market in tissue banking.
In almost all the countries, the law allows tissue donation with the consent of donor. In the United States, according to federal law, approval of family members is also required for tissue donation. Tissue donation saves the lives of many recipients but there also some grey areas in this market like profiteering a body's worth, ignoring the consent of family members, tissues for illegal immigrants and involving minorities etc.

To access / purchase the full report browse the link below
https://industryarc.com/Report/237/tissue-banking-market-research-analysis-report.html

Excerpts on Market Growth Factors:

Key factors that drive Global Tissue Banking Market are growth in the government initiatives and funding for stem cell research alongside evolution in regenerative medicine. Other factors such as evolution in regenerative medicine and increasing public awareness of stem cell treatments etc;
The increased awareness among people about tissue donation, government initiatives and increased healthcare spending will propel the market towards strong growth.
The market for Tissue Banking in the United States is expected to grow significantly in the light of the increased awareness about tissue donation and the large number of private and public tissue banks
The market in Australia is booming because of healthcare policies of the government and the drive among people to save millions of lives.

Increasing per capita income, improving infrastructure and private investment will boost the growth for tissue banking in Asia Pacific region.
The fastest emerging market in tissue banking is umbilical cord banking because of increased preference to regenerative medicines in response to the growing prevalence of chronic diseases.
Biobanking is becoming a lucrative market due to growing advancements in biotechnology, bio-informatics and genomics.
The predominance in strategic collaborations to stern up the product portfolio also resulting in the inclination of the growth.

Talk to one of our sales representatives about the full report by providing your details in the link below:
https://industryarc.com/support.php?id=237

Key players of Global Tissue Banking Market:

The global tissue banking market was chiefly dominated by Eppendorf AG, Brooks Automation, Inc, Tecan group, RTI Surgical, Inc. and Thermo Fisher Scientific.
The major leading players driving this market include Eppendorf AG, Brooks Automation, Inc, Tecan group, RTI Surgical, Inc. and Thermo Fisher Scientific. Other prominent players contributing to the market are CCLG Tissue Bank, Taylor-Wharton International LLC, Cureline Inc., Tissue Banks International and many others.
Key distributors such as Asterand Bioscience, Indivumed Inc. GmbH, IVTech Srl, Life Technologies Corporation, ABS, Becton Dickinson, GE Healthcare, Qiagen, Lifespan Biosciences, Inc;, National Disease Research Interchange (NDRI), Oncodesign, Morphosys AG, Promocell GmbH, Proteo Genex, Inc; Tristar Technology Group LLC, UK Human Tissue Bank, Xenotech, LLC, among others.
Companies such as Primegen Biotech, LLC DBA Reprocyte, Biolife Solutions Inc., and Sewon Cellontech Co., Ltd. have acquired patent for their respective tissue banking products.

Global Tissue Banking Market Report is segmented as indicated below

A. Global Tissue Banking Market – By Tissue Type

1. Blood
2. Bone
3. Skin
4. Soft tissues
5. Heart valves
6. Corneas
7. Umbilical Cord

B. Global Tissue Banking Market – By Equipment

1. Cryopreservation systems

1.1. Freezers
1.2. Liquid Nitrogen
1.3. Back Up storage systems
1.4. Others

2. Labeling and coding equipment
3. Thawing equipment
4. Quality Control equipment
5. Alarming and Monitoring Systems

B. Global Tissue Banking Market – By Application
1. Clinical/Therapeutic
1.1. Corneal Transplant
1.2. Heart Valve Transplant
1.3. Others
2. Medical Research
3. Cosmetics
3.1. Facial Rejuvenation
3.2. Breast Enhancement or Enlargement
3.3. Nasal Surgery
3.4. Others

C. Global Tissue Banking Market – By Service Type
1. Screening
2. Tissue Retrieval
3. Serological Testing
4. Microbial Testing
5. Processing
6. Storage and Preservation

D. Global Tissue Banking market – By End User

1. Hospitals
2. Tissue Banks
3. Research and Academic Institutes
4. Biotech companies
5. Ambulatory Surgery Centers
6. Others
E. Global Tissue Banking Market By Geography (Covers 12 + Countries)
F. Global Tissue Banking Market By Entropy

Companies Cited/Referenced/Interviewed:

1. Bone Bank Allografts
2. Biostorage Technologies Inc;
3. Americord Registry LLC.
4. Tata Memorial Hospital Tissue Bank
5. Lifenet Health Inc;
6. Novabone Products LLC;
7. Allosource
8. Lifelink Tissue Bank
9. Chernobyl Tissue Bank
10. Amsbio LLC
11. Biocision LLC

Related Reports:

A. Tissue Engineered n- Skin Substitutes Market
https://industryarc.com/Report/16380/tissue-engineered-skin-substitutes-market.html

B. 3D Printing in Healthcare Market
https://industryarc.com/Report/1268/3D-printing-in-healthcare-market-analysis.html

What can you expect from the report?

The Global Tissue Banking Market is Prepared with the Main Agenda to Cover the following 20 points:

1. Market Size by Product Categories
2. Market trends
3. Manufacturer Landscape
4. Distributor Landscape
5. Pricing Analysis
6. Top 10 End user Analysis
7. Product Benchmarking
8. Product Developments
9. Mergers & Acquisition Analysis
10. Patent Analysis
11. Demand Analysis (By Revenue & Volume)
12. Country level Analysis (15+)
13. Competitor Analysis
14. Market Shares Analysis
15. Value Chain Analysis
16. Supply Chain Analysis
17. Strategic Analysis
18. Current & Future Market Landscape Analysis
19. Opportunity Analysis
20. Revenue and Volume Analysis

Frequently Asked Questions:

Q. Does IndustryARC publish country, geography or application based reports in Global Tissue Banking Market?
Response: Yes, we do have separate reports as mentioned below:

1. Americas Market for Global Tissue Banking (2018-2023)
2. Europe Market for Global Tissue Banking (2018-2023)
3. APAC Market for Global Tissue Banking (2018-2023)
4. RoW Market for Global Tissue Banking (2018-2023)
5. By Tissue Type Global Tissue Banking (2018-2023)
6. By Equipment Global Tissue Banking (2018-2023)
7. By Application Global Tissue Banking (2018-2023)
8. By Service Type By End-User Global Tissue Banking (2018-2023)

Q. Does IndustryARC customize these reports and charge additionally for limited customization?
Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:

1. Increase the level of data in application or end user industry.
2. Increase the number of countries in geography chapter.
3. Find out market shares for other smaller companies or companies which are of interest to you.
4. Company profiles can be requested based on your interest.
5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.

Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

To request for a proposal, provide your details in the below link:
https://industryarc.com/subscription.php

Media Contact:

Mr. Venkat Reddy
Sales Manager
Email: venkat@industryarc.com
Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC:

IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications in a Market. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business.

We look forward to support the client to be able to better address their customer needs, stay ahead in the market, become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Venkat Reddy
IndustryARC
+1-614-588-8538 (Ext-101)
email us here


Source: EIN Presswire

Generalized Anxiety Disorder Market is estimated to grow at 2.5% CAGR to reach $7.5 billion by 2023

North America held the major share in global generalized anxiety disorder market, followed by Europe and Asia-Pacific region in terms of revenue

HYDERABAD, TELANGANA, INDIA, August 21, 2018 /EINPresswire.com/ — According to the new market research report by IndustryARC titled “Generalized Anxiety Disorder Market: By Therapeutics Type (Antidepressant, Benzodiazepines, Others); By Therapies( Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness-based Cognitive Therapy); By devices (Deep Brain Stimulation, Electroconvulsive Therapy, Trans cranial Magnetic Stimulation, Vagus Nerve Stimulation (VNS)) & By Geography – Forecast(2018-2023)”, the market is estimated to grow at 2.5% CAGR to reach $7.5 billion by 2023.

North America continues to lead the market share during 2018-2023:

North America held the major share in global generalized anxiety disorder market, followed by Europe and Asia-Pacific region in terms of revenue. In North America, Mexico is the leading country with 2.5% CAGR followed by Canada and the U.S. with 2.0% and 1.5% CAGR respectively. In Canada, the number of depression cases is likely to increase with the adoption of sedentary lifestyles. This has brought forward the newfound demand for development of therapeutics and is more likely to have a positive impact on the demand and growth for generalized anxiety disorder market.

The developments in mental health-care services and rising awareness towards anxiety disorders are responsible for the increase in the diagnosis of GAD in this region. The growing geriatric population is increasing the anxiety diagnosis rates in Mexico, thus directly boosting the demand for physiotherapies such as Cognitive Behavior Therapy (CBT) and GAD medication.

The sedentary lifestyle and stressful work environments are the major factors for the growing incidence of anxiety disorders in the U.S. According to Anxiety and Depression Association of America (ADAA), nearly 6.8 million people accounting to 3.1% of total population is affected by GAD every year. Moreover, the approval of several drugs including antidepressant drugs such as Paroxetine and Escitalopram, and benzodiazepine sedatives such as Alprazolam and Clonazepam is promising for the growth of therapeutic drugs in the U.S.
Anxiety and depressive disorders emerged as the two most common psychiatric illnesses across the globe.

According to WHO, Brazil has the highest prevalence of anxiety disorders in the world and the country ranks fifth in depression disorders. The Asia-Pacific region is estimated to witness fastest growth rate to reach $1.8 billion with a CAGR of 3.8 by 2023. It is expected to register healthy growth especially from India and China owing to the rising healthcare expenditure coupled with growing number of geriatric population with depression, anxiety and panic disorders. The transition of psychiatric services in Japan towards adoption of standardized diagnostic criteria and advanced antidepressant drugs such as selective serotonin, reuptake inhibitors are also increasing the prevalence of GAD.

Selected Type of Value Chain Analysis done in the full Report:

The value chain analysis deals with the comprehensive evaluation of each activity involved in the processing of any product/service and finally delivering it to the end-users. Each stage across the value chain of a product or service is associated with creating some sort of monetary value. The value chain analysis can offer the company a chance to examine every activity across the value chain and identify the steps where elimination or modification is essential.

The value chain of the generalized anxiety disorder market involves various stages such as research and development, clinical trials, regulatory agencies, distributors and end users.
Initially, the prototype is manufactured based on R&D and undergoes various phases of examination by regulatory bodies. It will get approved once it passes all the stages. These approved generalized anxiety disorders drugs are manufactured in bulk and are distributed directly or indirectly to end users.

To access/purchase the full report, click the link below:
https://industryarc.com/Report/15869/generalized-anxiety-disorder-market.html

Excerpts on Market Growth Factors Mentioned in the Full Report:

1. Generalized anxiety disorder market is experiencing growth globally owing to the rising instances of depression and global anxiety disorders among working class population due to extreme stress and busy lifestyles.
2. Aggregating healthcare expenditure coupled with the increasing number of FDA approved drugs for treating anxiety disorders is providing opportunities for manufactures to invest in research and product development of these drugs and expand their product portfolio.
3. Increasing stress and sedentary lifestyle is increasing the number of patients suffering from GAD and thus, driving the market growth globally.
4. Technological advancement in the pharmaceutical industry is slated to provide significant opportunity to the generalized anxiety disorder market.
5. Additionally, increasing public and private partnerships in the healthcare sector for R&D of generalized anxiety disorder drugs offers opportunity in the coming future for the GAD market.

Talk to one of our sales representatives about the full report by providing your details in the link below:
https://industryarc.com/support.php?id=15869

Key Players of the Generalized Anxiety Disorder Market:

Pfizer, Inc. and Eli Lilly and Company are analyzed to be the dominant players of the Generalized Anxiety Disorder market. The top 5 companies constitute more than 50% share in the total market globally. Acquisitions and partnerships are the key strategies adopted by the companies to enhance their market share.

Companies Cited/Referred/Interviewed:
Abbott Laboratories
Allergan plc
Bristol-Myers Squibb Company
F-Hoffmann-La Roche
GlaxoSmithKline plc.
Noven Pharmaceuticals, Inc.
Shionogi and company
Sumitomo Dainippon Pharma Co., Ltd.
Company 9
Company 10
Company 11
Company 12

Related Reports:

A. Panic Attack Treatment Market
https://industryarc.com/Report/15968/panic-attack-treatment-market.html

B. Anxiety Disorders and Depression Treatment Market
https://industryarc.com/Report/17373/anxiety-disorders-depression-treatment-market.html

Generalized Anxiety Disorder Market Report is Segmented as indicated below:
A. Generalized Anxiety Disorder Market, By Therapeutics Type
1. Antidepressant
1.1. Selective serotonin reuptake inhibitor (SSRI)
1.2. Serotonin norepinephrine reuptake inhibitor (SNRI)
1.3. Tricyclic antidepressant (TCA)
1.4. Monoamine Oxidase Inhibitors (MAOIs)
1.4.1. Benzodiazepines
1.4.2. Alprazolam
1.4.3. Chlordiazepoxide
1.4.4. Diazepam
1.4.5. Lorazepam
1.4.6. Others (Buspirone)
B. Generalized Anxiety Disorder Market, by Therapies type
1. Interpersonal Therapy (IPT)
2. Behaviour Therapy
3. Cognitive Behavioral Therapy (CBT)
4. Mindfulness-based Cognitive Therapy (MBCT)

C. Generalized Anxiety Disorder Market, by Medical devices type
1. Deep Brain Stimulation (DBS)
2. Electroconvulsive Therapy (ECT)
3. Trans cranial Magnetic Stimulation (TMS)
4. Vagus Nerve Stimulation (VNS)

D. Generalized Anxiety Disorder Market By Geography ( Covers 14+ Countries )
E. Generalized Anxiety Disorder Market Entropy
F. Company Profiles
G. Appendix: Abbreviations, Sources, Research Methodology, Bibliography, Compilation of Experts, Disclaimer.

What can you expect from the report?
The Generalized Anxiety Disorder Market Report is Prepared with the Main Agenda to Cover the following 20 points:
1. Market Size by Product Categories
2. Market trends
3. Manufacturer Landscape
4. Distributor Landscape
5. Pricing Analysis
6. Top 10 End user Analysis
7. Product Benchmarking
8. Product Developments
9. Mergers & Acquisition Analysis
10. Patent Analysis
11. Demand Analysis (By Revenue & Volume)
12. Country level Analysis (15+)
13. Competitor Analysis
14. Market Shares Analysis
15. Value Chain Analysis
16. Supply Chain Analysis
17. Strategic Analysis
18. Current & Future Market Landscape Analysis
19. Opportunity Analysis
20. Revenue and Volume Analysis

Frequently Asked Questions:

Q. Does IndustryARC publish country, geography or application based reports in Generalized Anxiety Disorder?

Response: Yes, we do have separate reports and database as mentioned below:

1. North America Market for Generalized Anxiety Disorder (2018-2023)
2. Asia-Pacific Market for Generalized Anxiety Disorder (2018-2023)
3. Europe Market for Generalized Anxiety Disorder (2018-2023)
4. By Type Generalized Anxiety Disorder (2018-2023)
5. By Therapies type Benzodiazepines Market for Generalized Anxiety Disorder (2018-2023)
6. By Medical Devices Type Benzodiazepines Market for Generalized Anxiety Disorder (2018-2023)

Q. Does IndustryARC provide customized reports and charge additionally for limited customization?
Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:

1. Increase the level of data in application or end user industry.
2. Increase the number of countries in geography or product chapter.
3. Find out market shares for other smaller companies or companies which are of interest to you.
4. Company profiles can be requested based on your interest.
5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.

Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

To request for a proposal, provide your details in the below link:
https://industryarc.com/subscription.php

Media Contact:

Mr. Venkat Reddy
Sales Manager
Email: venkat@industryarc.com
Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC:

IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences &Healthcare.

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications in a Market. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business.

We look forward to support the client to be able to better address their customer needs, stay ahead in the market, become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Venkat Reddy
IndustryARC
+1-614-588-8538 (Ext-101)
email us here


Source: EIN Presswire

Johannesburg gets ready for 4th Healthcare Innovation Summit Africa

HISA 2018

Transforming Healthcare with Technology

JOHANNESBURG, GAUTENG, SOUTH AFRICA, August 21, 2018 /EINPresswire.com/ — The 4th Annual Healthcare Innovation Summit Africa is scheduled for 17-18 October 2018 at the Gallagher Convention Centre, Johannesburg, South Africa. The conference will attract over 300+ hospital CxOs, medical practitioners, healthcare IT leaders, service providers and government functionaries, as well as a carefully selected roster of local and international speakers.

HISA 2018 joins the dots between innovation and practicality, presenting the latest healthcare technologies and showcasing their practical application and integration into existing healthcare infrastructure. Under the theme “Transforming Healthcare with Technology”, the agenda will cover emerging technology trends in healthcare such as AI, IoT and wearables, electronic health records, healthcare data security and privacy, telemedicine, predictive analytics and much more. It will also look at the impact that these technologies have on hospital operations and healthcare delivery.

Why Attend?

– Discover the latest trends: Under one roof you will find cutting edge digital healthcare solutions that will move your organisation to greater heights.
– Develop a Roadmap: Discover tomorrow’s healthcare innovation tools to solve critical issues and create a clear vision for your organisation.
– Overcome Challenges: Address the challenges specific to your healthcare organisation with our tracks, workshops and discussion streams.
– International and Local Case Studies: Hear real transformation stories that you can implement in your organization to alleviate your challenges.
– Connect: Connect with over 300 worldwide senior healthcare executives in a unique environment of collaboration
– Transformation – digital healthcare is constantly evolving, don’t get left behind

Confirmed speakers for HISA 2018:

– Rajeev R. Eashwari, Director: eHealth, KZN Provincial Department of Health
– Etienne Dreyer, Associate Director: PwC
– Leonard Slabbert, CTO: Boehringer Ingelheim, Sub-Sahara Africa
– Reg Courtenay, Deputy Director: IT Systems in Health, Joburg City
– Dr Kofi Okyere-Dede, Medical Doctor & “Ideas Guy” for Novitech Digital
– Mike Perk, CEO at WWC

Click here to view speakers

Key topics at this HISA 2018 include:

– Developing a Digitally Enabled Workforce.
– The Role of Technology in Making NHI a Success.
– How Practical is Robotic Healthcare Within the African Context?
– Artificial Intelligence and the Future of African Healthcare.
– Electronic Health Records: Data Security Risks, Privacy and Regulatory Compliance.
– Emerging Trends and Opportunities in the eHealth Market.
– The Role of Big Data and Predictive Analytics in Healthcare.
– Digitizing and Automating the Distribution and Dispensing of Medication.
– Measuring the ROI of Digital Healthcare Projects.
– IoT and Wearables in Healthcare.
– Assessing the Efficacy of Technology-Enabled Population Health Management Systems.

How to Participate:

Join as an attendee: Join local and international hospital CxOs, medical practitioners, healthcare IT leaders, service providers and government functionaries – for two days of top-level content, case studies, live demos, breakaway sessions and plenty of networking opportunities.

Join us as an exhibitor: Showcase your health-tech innovations, projects, and solutions. Put your organisation at the centre of this one-of-a-kind gathering. Find new partnerships, investors, leads, and opportunities.

For more information about this conference, visit http://www.healthcareinnovationsummit.co.za/

Matshego Njumbuxa
IT News Africa
110260981
email us here


Source: EIN Presswire

Digital Practice Inc. Chooses PCIHIPAA to Protect Healthcare Providers with HIPAA Compliance

Digital Practice Inc - HIPAA Compliance - PCIHIPAA Partnership

The partnership will provide Digital Practice Inc. practices a comprehensive compliance program that helps them save time & money navigating HIPAA requirements.

The partnership will provide Digital Practice Inc. practices a comprehensive compliance program that helps them save time & money navigating HIPAA requirements.”

— Nam Ko, President, Digital Practice Inc

KANOEHE, HAWAII, UNITED STATES, August 20, 2018 /EINPresswire.com/ — KANOEHE, HAWAII, UNITED STATES, August 8, 2018 /EINPresswire.com/ — Digital Practice Inc (DPI) announced today its partnership with PCIHIPAA, a leading Payments Card Industry (PCI) and HIPAA compliance provider. The partnership is focused on protecting DPI clients from the onslaught of HIPAA violations which include ransomware attacks and data breaches impacting medical and dental practices throughout the United States. Under HIPAA’s Security and Privacy Rules, healthcare providers are required to take proactive steps to protect sensitive patient information. The partnership comes on the heels of an important announcement surrounding HIPAA compliance regulation. The Director of the U.S. Department of Health and Human Services’ Office for Civil Rights recently stated, "Just because you are a small medical or dental practice doesn't mean we're not looking and that you are safe if you are violating the law. You won't be." In addition, according to the HHS website, over 870,000 patient records were breached in the month of July 2018 .Protected Health Information (PHI) continues to be under attack as hackers strive to monetize the stolen data on the dark web.

Digital Practice Inc. has been providing comprehensive high tech solutions for dental practices that are both functional and aesthetically pleasing. Now, it is more important than ever for DPI to take a leadership role in helping our clients make patient data privacy and security a top priority. We vetted many HIPAA compliance providers and believe PCIHIPAA’s OfficeSafe Compliance Program is the right solution for our clients. Our partnership adds another quality layer of protection for our clients. It's easy to implement and I'm confident our clients will experience savings, convenience and peace of mind." said Nam Ko, President, Digital Practice Inc.

According to the U.S. Department of Health and Human Services, OCR has received over 150,000 HIPAA complaints following the issuance of the Privacy Rule in April 2003. A rising number of claims filed under HIPAA in recent years have led many patients to question whether or not their personal payment and health information is safe. As the government has become more aggressive in HIPAA enforcement, large settlements have become widespread and rising penalties for HIPAA non-compliance are a reality. According to HHS.gov, the types of HIPAA violations most often identified are:

1) Impermissible uses and disclosures of protected health information (PHI)
2) Lack of technology safeguards of PHI
3) Lack of adequate contingency planning in case of a data breach or ransomware attack
4) Lack of administrative safeguards of PHI
5) Lack of a mandatory HIPAA risk assessment
6) Lack of executed Business Associate Agreements
7) Lack of employee training and updated policies and procedures

“We are excited to be working with the owners, Nam & Sam, and their excellent team at Digital Practice, Inc. They have a proud history of providing IT solutions for growing practices. If Equifax can get breached so can a healthcare provider. We find that many practices don't have the resources to navigate HIPAA law, and are unaware of common vulnerabilities. We're excited to add the OfficeSafe Compliance Program to DPI’s extensive suite of services. We invite every member to conduct a complimentary Self-Assessment to quickly identity key vulnerabilities in their practice.” said Jeff Broudy, CEO of PCIHIPAA.

Jeff Broudy
PCIHIPAA
8185195897
email us here


Source: EIN Presswire

Intermountain Healthcare and Stanford University School of Medicine establish fellowship program

The two-year fellowship will support the education and training of the next generation of leaders in population health, primary care, and care delivery science

SALT LAKE CITY, UTAH, USA, August 20, 2018 /EINPresswire.com/ — Intermountain Healthcare and the Stanford University School of Medicine have launched a fellowship program that began in July.

The two-year Stanford-Intermountain Population Health and Care Delivery Science Fellowship will support the education and training of the next generation of leaders in population health, primary care, and care delivery science. Developing leaders in these areas is crucial to meeting the challenges of a rapidly changing healthcare system and to transition healthcare to a broader focus on populations, value, and service over visits.

“The fellowship program is part of an exciting collaboration that focuses on advancing clinical care best practices, education and training, and clinical research,” says Raj Srivastava, MD, MPH, Assistant Vice President Research and fellowship co-director. “The purpose of the fellowship is to take advantage of the two institutions’ synergies in research, system implementation design, and strong desire to deploy effective evidence-based interventions in both health care systems.”

The first two fellows in the program are Stacie Marie Vilendrer, MD, MBA, and Harris Lee Carmichael, MD.

Dr. Vilendrer recently finished her family physician residency at Sutter Santa Rosa Regional Hospital, a UCSF-affiliate with a focus on healthcare delivery innovation. Dr. Vilendrer has strong clinical experience in internal medicine, pediatrics, obstetrics, geriatrics, and focused training in integrative/functional medicine and global health. She obtained her MD from Stanford with a concentration in health policy and bioinformatics.

Dr. Carmichael recently finished as the chief medical resident, University of Utah, internal medicine, with strong experience in biomedical sciences and research. He obtained his MD from the Medical College of Georgia-Augusta University, and undergraduate degree at Auburn University.

Each fellow will assemble a formal mentorship team with at least one core faculty member from each institution to help them develop a project from existing efforts at Intermountain or at one of Stanford’s affiliated research centers (e.g. the Center for Population Health Sciences, the Clinical Excellence Research Center and the VA Center for Innovation to Implementation).

The first year of the fellowship consists of coursework and participating in seminars in which they fellows have the opportunity to present their work. The second year will be devoted to the fellow’s project interspersed with a tailored 2-4 week Advanced Training Program at the Intermountain Healthcare Delivery Institute in quality improvement methods and evaluation. In addition, fellows will continue their clinical work consistent with training at either institution.

“The best care and best research are interdisciplinary. We need to train healthcare leaders to confront current and future problems of healthcare delivery by educating them in the scientific discovery and implementation process,” says Steve Asch MD, MPH, fellowship co-director and vice chief of primary care and population health at Stanford. “Our strategic partnership with Intermountain is intended to accelerate the scientific discovery process for both institutions and lead to improved patient care and affordability.”

Daron Cowley
Intermountain Healthcare
801-442-2834
email us here


Source: EIN Presswire

Local, former professional hockey player gives Athletes for Care home-ice advantage in charity all-star tournament

Retired professional hockey player, Marvin Degon IV and the Athletes for CARE team hit the ice on Sunday

Retired professional hockey player, Marvin Degon IV and the Athletes for CARE team hit the ice on Sunday

FORT MYERS , FLA. , UNITED STATES , August 20, 2018 /EINPresswire.com/ — Retired professional hockey player, Marvin Degon IV, a Naples, Florida resident, participated in the Hockey Summit Pro All-Star Tournament on Sunday at the Fort Myers Skatium Arena to benefit charity.

Degon, who now serves as director of athletics for VEDA Endocannabinoid Nutrition, laced up his skates Sunday for the summit’s 3×3 all-star tournament with proceeds benefiting Athletes for CARE, a 501(c)3 non-profit organization.

The Hockey Summit is an off-season training platform designed to provide the most comprehensive training environment for professional hockey players all under one roof.

“Using the most advanced training technology, DNA nutritional testing, on ice video teaching methods, and recovery techniques, we leave nothing to chance in ensuring every individual need is addressed and developed to improve performance and prolong careers for our athletes.” said, Justin Roethlingshoefer, the strength and conditioning coach for the Anaheim Ducks and co founder of the program with Everblades great Ernie Hartlieb.

The Hockey Summit worked with Athletes For Care to put together The Pro Week Weekend as an extended benefit to the athletes and the communities where they play.

“We are dedicated to creating a community where athletes can find support, opportunity and purpose in life after a career in sports so teaming up with Justin and Ernie made perfect sense.” said Riley Cote, founder of Athletes for CARE.

Athletes For CARE is the first-of-its-kind in professional sports. The non-profit serves as a global advocacy and support organization created by athletes for athletes. Their mission is to raise awareness for critical health and safety issues that impact athletes of all ages and promote solutions that lead to a better quality of life.

Degon, a veteran professional hockey player with a 10 year career, knows firsthand how having access to cutting edge support systems can benefit an athlete’s success rate. He is also familiar with the struggles that can come after retirement.

“I’m excited to educate athletes on life after the sport and the nutritional alternatives that are both natural and sustainable to help them deal with the toll taken on their bodies as athletes at the professional level,” said Degon. “Athletes for Care has led the way and introduced the conversation of cannabis and hemp products into the athletic world. I’m excited be a part of the continued movement and assist in providing an educational platform.”

About VEDA:
VEDA was founded by a unique group of experts in agricultural science, chemistry, biology, healthcare, and finance. VEDA has been developed to address the overwhelming deficiency in Endocannabinoid Nutrition (ECN) that affects the health and well-being of individuals all over the world.

VEDA products are formulated to provide the highest bioavailability, the most effective delivery systems and to ensure customer accessibility and affordability. Driven by principles and quality, at VEDA we are dedicated to having a profound impact on humanity. We believe everyone should have access to quality ECN to enhance health.

VEDA provides a variety of ECN products including; tincture, spray and vape. The VEDA Active line is set to launch Fall 2018.

VEDA ECN is a subsidiary of Avant Garde Holdings Americas, Inc., dba AG Health, a research and development company of bio-pharmaceutical products, big data analytics, health information and disease management, drug formulations and commerce solutions for the U.S. cannabis and hemp industry.

For more information on AGH, visit the company’s website at https://avantgardeholdings.net

James Judge
Judge Public Relations
813.279.8335
email us here


Source: EIN Presswire

ProScribe Recognized by Inc. 500|5000 List as Nation’s 1,610th fasting-growing private company in 2018

2018 Inc. 500|5000 List ranks ProScribe as the 1,610th fastest-growing private company in America with a 289% growth over the last three years.

I want to congratulate every ProScribe employee that contributed to this outstanding achievement. We have always put our clients first, which is reflected in our outstanding client retention rate.”

— Toby Mulligan

SAN ANTONIO, TEXAS, UNITED STATES, August 20, 2018 /EINPresswire.com/ — ProScribe has been recognized as the nation’s 1,610th fastest-growing private company in America by Inc. Magazine’s 500|5000 list.

ProScribe is a full-service in-person and virtual medical scribe vendor that was founded in 2010 to offset the burden of Electronic Health Record (EHR) documentation requirements. Provider burnout is at an all-time high due to EHR requirements and as a result, providers are spending less time interacting with their patients and more time entering data into their EHR.

ProScribe enables healthcare providers to put their focus back on their patients and boost their productivity while decreasing burnout. They specialize in recruiting, hiring, and training medical scribes to document into the EHR on behalf of the provider.

With over 1900 medical scribes operating across the nation, ProScribe is the recognized leader in providing the best-trained medical scribes and the most reliable shift coverage in the industry. For the past two years, they have covered 99.8% of all contracted shifts. Furthermore, ProScribe delivers these outstanding services at cost-effective rates.

“I want to congratulate every ProScribe employee that contributed to this outstanding achievement. We have always put our clients first, which is reflected in our outstanding client retention rate. We expect exponential growth over the next 3 years as more health systems recognize the benefits we offer to their providers and as we continue to convert other underperforming scribe programs to ProScribe.” – Toby Mulligan, CEO of ProScribe.

ProScribe utilizes a turnkey program model to provide specialized medical scribe programs for an array of healthcare providers in clinics, healthcare systems, and hospitals from coast to coast.

ProScribe’s success is based on creating true partnerships and providing the highest quality medical scribes, reliable coverage and responsive customer service. They credit their success to their corporate team who puts the care of their customers and employees above all else. ProScribe is excited about the future growth of the company and improving the quality of healthcare in the United States.

About ProScribe

ProScribe is one of the nation’s fastest-growing providers of in-person and virtual medical scribe services. Our innovative recruitment, training and quality assurance programs have successfully proven to increase physician productivity, patient satisfaction and improve physicians’ quality of life in a wide variety of practice settings.

Toby Mulligan
ProScribe
210-545-2500
email us here


Source: EIN Presswire